The role of phospholipases A2 in the stimulation of neutrophil motility by cobra venoms

Toxicon

Volumn 41, Issue 4, 2003, Pages 459-468

  Sundell, I Birgitta ^a   Aziz, Khalil A ^a   Zuzel, Mirko ^a   Theakston, R David G ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Annexin V; Cobra venoms; Inflammation; PLA2s; PMN motility

Indexed keywords

ARISTOLOCHIC ACID; COLLAGENASE INHIBITOR; LIPOCORTIN 5; LIPOXYGENASE; METHYLARACHIDONYLFLUOROPHOSPHONATE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN SYNTHASE; SNAKE VENOM; UNCLASSIFIED DRUG; ALPHA2 INTEGRIN; ARISTOLOCHIC ACID I; CD11B ANTIGEN; INTEGRIN; PHOSPHOLIPASE A;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENDOCYTOSIS; ENVENOMATION; ENZYME ACTIVITY; ENZYME BINDING; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; NEUTROPHIL; PRIORITY JOURNAL; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; NEUTROPHIL CHEMOTAXIS; SNAKE;

ELAPIDAE; NAJA; NAJA MOSSAMBICA; NAJA NAJA;

ANIMALS; ANTIGENS, CD11B; ARISTOLOCHIC ACIDS; CHEMOTAXIS, LEUKOCYTE; COBRA; COBRA VENOMS; GENE EXPRESSION REGULATION; INTEGRIN ALPHA2; INTEGRINS; NEUTROPHILS; PHOSPHOLIPASES A;

EID: 0037377294     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(02)00365-3     Document Type: Article

References (60)

1. Anderson S.I., Hotchin N.A., Nash G.B. Role of the cytoskeleton in rapid activation of CD11b/CD18 function and its subsequent downregulation in neutrophils. J. Cell Sci. 113:2000;2737-2745.
2. Aziz, K.A., 1994. Influence of GM-CSF and G-CSF on the initial interactions between platelets and neutrophils. PhD Thesis, University of Liverpool.
3. Aziz K.A., Cawley J.C., Treweeke A.T., Zuzel M. Sequential potentiation and inhibition of PMN reactivity by maximally stimulated platelets. J. Leukoc. Biol. 61:1997;322-328.
4. Aziz K.A., Till K.J., Zuzel M., Cawley J.C. Involvment of CD44-hyaluronan interaction in malignant cell homing and fibronectin synthesis in hairy cell leukaemia. Blood. 96:2000;3161-3167.
5. 1 macrophages. J. Biol. Chem. 271:1996;6758-6765.
6. 2 from Indian cobra (Naja naja naja) venom. Toxicon. 30:1992;1227-1238.
7. 2: interfacial parameters, substrate specificities, and competitive inhibitors. Biochemistry. 32:1993;573-582.
8. 2) from the Indian cobra (Naja naja naja) venom. Biochem. Int. 25:1991;1023-1034.
9. 2. Biochim. Biophys. Acta. 1391:1998;367-376.
10. Carnevale K.A., Cathcart M.K. Calcium-independent phospholipase A(2) is required for human monocyte chemotaxis to monocyte chemoattractant protein 1. J. Immunol. 167:2001;3414-3421.
11. Davey P.C., Zuzel M., Kamiguti A.S., Hunt J.A., Aziz K.A. Activation-dependent proteolytic degradation of polymorphonuclear CD11b. Br. J. Haematol. 111:2000;934-942.
12. 2 into the rat pleural cavity. Toxicon. 38:2000;1773-1785.
13. Declaux C., Delacourt C., D'Ortho M.P., Boyer V., Lafuma C., Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am. J. Respir. Cell. Mol. Biol. 14:1996;288-295.
14. Dematos I.M., Rocha O.A., Leite R., Freire-Maia L. Lung oedema induced by Tityus serrulatus scorpion venom in the rat. Com. Biochem. Physiol. 118C:1997;143-148.
15. Farsky S.H.P., Walber J., Costa-Cruz M., Cury Y., Teixeira C.F.P. Leukocyte response induced by Bothrops jararaca crude venom: in vivo and in vitro studies. Toxicon. 35:1997;185-193.
16. Flores C.A., Zappellini A., Prado-Franceschi J. Lipooxygenase-derived mediators may be involved in in vivo neutrophil migration induced by Bothrops erythromelas and Bothrops alternatus venoms. Toxicon. 31:1993;1551-1559.
17. Gutierrez J.M., Ownby C.L., Odell G.V. Isolation of a myotoxin from Bothrops asper venom: partial characterization and action on skeletal muscle. Toxicon. 22:1984;115-128.
18. Gutierrez J.M., Craves F., Mata E., Cerdas L. Skeletal muscle regeneration after myonecrosis induced by Bothrops asper (terciopelo) venom. Toxicon. 24:1986;223-231.
19. Hamako J., Matsui T., Nishida A.S., Nomura S., Fujimura Y., Ozeki Y., Titani K. Purification and characterization of kaouthiagin, a von Willebrand factor-binding and cleaving metalloproteinase from Naja kaouthia cobra venom. Thromb. Haemost. 80:1998;499-505.
20. Harvath L., Falk W., Leonard E.J. Rapid quantification of neutrophil chemotaxis: use of a polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly. J. Immunol. Methods. 37:1980;39-45.
21. 2 from Ophiophagus hannah venom on heart and skeletal muscle of mice after systemic injection. Toxicon. 34:1996;201-211.
22. 2 from Ophiophagus hannah snake venom. Life Sci. 61:1997;2211-2217.
23. Iddon D., Theakston R.D.G., Ownby C.L. A study of the pathogenesis of local skin necrosis induced by Naja nigricollis (spitting cobra) venom using simple histological staining techniques. Toxicon. 25:1987;665-667.
24. Kaiser E., Michl H. Chemistry and pharmacology of the venoms Bothrops and Lachesis. Bücherl W., Buckley E.E. Venomous Animals and their Venoms. vol. 2:1971;307-318 Academic Press, New York.
25. 2 platelet inhibitor. Toxicon. 32:1994;915-925.
26. Kuntz R.M., Saltzman W.M. Neutrophil motility in extra cellular matrix gels: mesh size and adhesion affects speed of migration. Biophys. J. 72:1997;1472-1480.
27. 2. TiPS. 20:1999;162-170.
28. 2 by quercetin. Inflammation. 17:1993;573-582.
29. 2 in arachidonic acid release from human neutrophils. J. Immunol. 164:2000;2084-2091.
30. 2 in the spitting cobra (Naja mossambica mossambica) venom. Toxicon. 17:1979;127-136.
31. 4 by human neutrophils. J. Biol. Chem. 131:1987;2397-2403.
32. Moura-da-Silva A.M., Laing G.D., Paine M.J.I., Dennison J.M.T.I., Politi V., Crampton J.M., Theakston R.D.G. Processing of pro-TNF-α by venom metalloproteinase: a hypothesis towards explaining local tissue damage following snake bite. Eur. J. Immunol. 26:1996;2000-2005.
33. 2 enzymes: regulation and physiological role. Biochem. Pharmacol. 48:1994;1-10.
34. Murphy G., Reynolds J.J., Bretz U., Baggiolini M. Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens. Biochem. J. 203:1982;209-221.
35. Netzel-Arnett S., Fields G., Birkedal-Hansen H., van Wart E. Sequence specificity of human fibroblast and neutrophil collagenases. J. Biol. Chem. 226:1991;6747-6755.
36. Ogino M., Majima M., Kawamura M., Hatanaka K., Saito M., Harada Y., Katori M. Increased migration of neutrophils to granulocyte-colony stimulating factor in rat carrageenin-induced pleurisy: roles of compliment, bradykinin, and inductible cyclo-oxygenase-2. Inflamm. Res. 45:1996;335-346.
37. Pugh R.N.H., Theakston R.D.G., Reid H.A., Bahr I.S. Malumfashi endemic diseases research project XIII: epidemiology of human encounters with the spitting cobra, Naja nigricollis, in the Malumfashi area of Northern Nigeria. Ann. Trop. Med. Parasit. 74:1980;523-530.
38. Rosenfeld G. Symptomatology, pathology and treatment of snake bites in South America. Bücherl W., Buckley E.E. Venomous Animals and their Venoms. vol. 2:1971;345-362 Academic Press, New York.
39. 2 activity and arachidonate metabolism on human neutrophils. Biochem. Biophys. Acta. 1001:1989;1-8.
40. 2 inhibitors aristolochic acid and PGBx on A23187-stimulated mobilization of arachidonate in human neutrophils are overcome by diacylglycerol or phorbol ester. Biochem. Biophys. Acta. 1126:1992;319-326.
41. 2 in uterine stromal cells. Biochem. J. 315:1999;1007-1014.
42. 2 from Indian cobra (Naja naja naja) venom. Toxicon. 36:1998;639-644.
43. Saltzman W.M., Livingston T.L., Parkhurst M.R. Antibodies to CD18 influence neutrophil migration through extracellular matrix. J. Leukoc. Biol. 65:1999;356-363.
44. Schmid E., Warner R.L., Crouch L.D., Friedl H.P., Till G.O., Hugli T.E., Ward P.A. Neutrophil chemotactic activity and C5a following systemic activation of complement in rats. Inflammation. 21:1997;325-333.
45. Sheikh S., Nash G.B. Continuous activation and deactivation of integrin CD11b/CD18 during de novo expression enables rolling neutrophils to immobilise on platelets. Blood. 87:1996;5040-5050.
46. 4 metabolism. J. Immunol. 138:1987;3918-3926.
47. 2. FEBS Lett. 402:1997;193-197.
48. Sundell I.B., Theakston R.D.G., Kamiguti A.S., Harris R.J., Treweeke A.T., Laing G.D., Fox J.W., Warrell D.A., Zuzel M. The inhibition of platelet aggregation and blood coagulation by Micropechis ikaheka venom. Br. J. Haem. 114:2001;852-860.
49. 4 in chemotactic peptide-stimulated human neutrophils. FASEB J. 12:1998;1521-1531.
50. Theakston R.D.G., Phillips R.E., Warrell D.A., Galagedera Y., Abeysekera D.T.D.J., Dissanayaka P., de Silva A., Aloysius D.J. Envenoming by the common krait (Bungarus caeruleus) and Sri Lankan cobra (Naja naja naja): efficacy and complications of therapy with Haffkine antivenom. Trans. R. Soc. Trop. Med. Hyg. 84:1990;301-308.
51. Treweeke A.T., Aziz K.A., Zuzel M. The role of G-CSF in mature neutrophil function is not related to CM-CSF-type cell priming. J.Leukoc. Biol. 55:1994;612-636.
52. 2: its effect on enzymatic and pathological activities. Toxicon. 25:1987;929-937.
53. 2 enzymes from Habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon. 25:1987;501-515.
54. 2 from Vipera russelli venom with aristolochic acid: a circular dichroism study. Toxicon. 25:1987;939-946.
55. Ward C.M., Vinogradov D.V., Andrews R.K., Berndt M.C. Characterization of mocarhagin, a cobra venom metalloproteinase from Naja mocambique mocambique, and related proteins from other Elapidae venoms. Toxicon. 34:1996;1203-1206.
56. Warner R.L., Glovsky M.M., Pangburn M.K., Ward P.A. Effects of polymeric C3, C3b and iC3b on neutrophil expression of CD11b and CD18. Int. Arch. Allergy Immunol. 113:1997;368-369.
57. 1 integrins are critically involved in neutrophil locomotion in extravascular tissue in vivo. J. Exp. Med. 187:1998;2091-2096.
58. 1 (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue. Blood. 95:2000;1804-1809.
59. Yasiu K., Yamazaki M., Miyabayashi M., Tsuno T., Komiyama A. Signal transduction pathway in human polymorphonuclear leucocytes for chemotaxis induced by a chemotactic factor; distinct from the pathway for superoxide anion production. J. Immunol. 152:1994;5922-5929.
60. 2 stimulates neutrophils to provoke the release of cytotoxic agents. Arch. Surg. 133:1998;1229-1233.